MoneyWorks4Me

Transgene Biotek - Quaterly Results

07 May 2025 Evaluate
The turnover zoomed to Rs. 0.77 millions, up 71.11% for the March 2025 quarter as against Rs. 0.45 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -7.13 millions as compared to Net Loss of Rs. -2.72 millions of corresponding quarter ended March 2024 Operating profit Margin for the quarter ended March 2025 further decreased to -4.98% as compared to -2.17% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 0.77 0.45 71.11 2.61 2.35 11.06 2.61 2.35 11.06
Other Income 0.44 0.51 -13.73 7.84 1.83 328.42 7.84 1.83 328.42
PBIDT -4.98 -2.17 129.49 -3.40 -4.34 -21.66 -3.40 -4.34 -21.66
Interest 1.91 0.32 496.88 2.43 1.29 88.37 2.43 1.29 88.37
PBDT -6.89 -2.49 176.71 -5.83 -5.63 3.55 -5.83 -5.63 3.55
Depreciation 0.24 0.23 4.35 0.93 0.92 1.09 0.93 0.92 1.09
PBT -7.13 -2.72 162.13 -6.76 -6.55 3.21 -6.76 -6.55 3.21
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -7.13 -2.72 162.13 -6.76 -6.55 3.21 -6.76 -6.55 3.21
Equity 757.70 757.70 0.00 757.70 757.70 0.00 757.70 757.70 0.00
PBIDTM(%) -646.75 -482.22 34.12 -130.27 -184.68 -29.46 -130.27 -184.68 -29.46
Peers
Company Name CMP
Sagility 45.15
Knowledge RealtyTrt. 113.28
Prime Focus 310.60
Indegene 578.05
Syngene Internatl. 382.65
View more..